Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock

Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter...

Full description

Bibliographic Details
Main Authors:	Ivan D. Hanson, Pratik K. Dalal, Brian M. Renard, George S. Hanzel, Alessandro Vivacqua
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Case Reports in Cardiology
Online Access:	http://dx.doi.org/10.1155/2018/6872748

id	doaj-2108d7a38a7845a783c9099e7e8e78e4
record_format	Article
spelling	doaj-2108d7a38a7845a783c9099e7e8e78e42020-11-24T21:43:43ZengHindawi LimitedCase Reports in Cardiology2090-64042090-64122018-01-01201810.1155/2018/68727486872748Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic ShockIvan D. Hanson0Pratik K. Dalal1Brian M. Renard2George S. Hanzel3Alessandro Vivacqua4Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USADepartment of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USADepartment of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USADepartment of Cardiovascular Medicine, Beaumont Health System, Royal Oak, MI, USADepartment of Cardiovascular Surgery, Beaumont Health System, Royal Oak, MI, USABioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.http://dx.doi.org/10.1155/2018/6872748
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Ivan D. Hanson Pratik K. Dalal Brian M. Renard George S. Hanzel Alessandro Vivacqua
spellingShingle	Ivan D. Hanson Pratik K. Dalal Brian M. Renard George S. Hanzel Alessandro Vivacqua Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock Case Reports in Cardiology
author_facet	Ivan D. Hanson Pratik K. Dalal Brian M. Renard George S. Hanzel Alessandro Vivacqua
author_sort	Ivan D. Hanson
title	Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
title_short	Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
title_full	Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
title_fullStr	Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
title_full_unstemmed	Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock
title_sort	emergency valve-in-valve transcatheter aortic valve implantation for the treatment of acute stentless bioprosthetic aortic insufficiency and cardiogenic shock
publisher	Hindawi Limited
series	Case Reports in Cardiology
issn	2090-6404 2090-6412
publishDate	2018-01-01
description	Bioprosthetic aortic valve degeneration may present as acute, severe aortic regurgitation and cardiogenic shock. Such patients may be unsuitable for emergency valve replacement surgery due to excessive risk of operative mortality but could be treatable with transfemoral valve-in-valve transcatheter aortic valve implantation (TAVI). There is a paucity of data regarding the feasibility of valve-in-valve TAVI in patients presenting with cardiogenic shock due to acute aortic insufficiency from stentless bioprosthetic valve degeneration. We present one such case, highlighting the unique aspects of valve-in-valve TAVI for this challenging patient subset.
url	http://dx.doi.org/10.1155/2018/6872748
work_keys_str_mv	AT ivandhanson emergencyvalveinvalvetranscatheteraorticvalveimplantationforthetreatmentofacutestentlessbioprostheticaorticinsufficiencyandcardiogenicshock AT pratikkdalal emergencyvalveinvalvetranscatheteraorticvalveimplantationforthetreatmentofacutestentlessbioprostheticaorticinsufficiencyandcardiogenicshock AT brianmrenard emergencyvalveinvalvetranscatheteraorticvalveimplantationforthetreatmentofacutestentlessbioprostheticaorticinsufficiencyandcardiogenicshock AT georgeshanzel emergencyvalveinvalvetranscatheteraorticvalveimplantationforthetreatmentofacutestentlessbioprostheticaorticinsufficiencyandcardiogenicshock AT alessandrovivacqua emergencyvalveinvalvetranscatheteraorticvalveimplantationforthetreatmentofacutestentlessbioprostheticaorticinsufficiencyandcardiogenicshock
_version_	1725912359453589504

Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock

Similar Items